Strategic Focus Target MS care ecosystems with Octave’s MSDA test as a centerpiece for longitudinal disease management, aligning with MS centers, patient advocacy groups, and health systems to drive adoption across clinics and networks.

Clinical Validation Leverage peer‑reviewed publications and Quest Diagnostics collaboration to position Octave as a credible, evidence‑based tool that supports treatment decisions, encouraging payer discussions and reference lab partnerships.

Revenue Expansion Capitalizing on current revenue mix and national availability, target hospital systems and specialty labs for scaled distribution, while highlighting data‑driven insights that can unlock additional test menus and adjacent biomarkers.

Tech Enablement Offer seamless integration with existing healthcare IT and data platforms (Snowflake, Redshift, Databricks, Sage Intacct) to streamline ordering, results reporting, and financial workflows for clinics and health systems.

Strategic Partnerships Highlight collaboration opportunities with MS centers, insurers, and health networks to expand coverage, co‑develop payer‑relevant outcomes data, and accelerate adoption through bundled or value‑based pricing.